Skip to main content

News

Where hypotheses become headlines: Featured coverage of the breakthroughs—and the people—driving our research forward

For media inquiries, email us: [email protected]


Featured News
Greg Tabor
News

Paying It Forward: Greg Tabor on Giving Back to the Next Generation

New research offers fresh insights for how to make better vaccines
News

New research offers fresh insights for how to make better vaccines

Filter by:
  • Scripps Research scientist Evert Njomen awarded prestigious Howard Hughes Medical Institute fellowship
    News

    Scripps Research scientist Evert Njomen awarded prestigious Howard Hughes Medical Institute fellowship

    The Hanna H. Gray Fellowship supports early career life scientists and promotes diversity within the biomedical research community.

  • Thomas Scott Edgington – Polymath, Colleague, Mentor, Friend
    News

    Thomas Scott Edgington – Polymath, Colleague, Mentor, Friend

    Thomas Edgington, an outstanding scientist and a world leader in the field of vascular biology, passed away Jan. 22, 2021. He enjoyed a 55 year career at Scripps Research.

    Thomas Edgington
  • Experts call for streamlined lab tests of SARS-CoV-2 variants to spot worrisome features
    News

    Experts call for streamlined lab tests of SARS-CoV-2 variants to spot worrisome features

    Rapid genetic sequencing of COVID-19 virus samples isn’t enough; standardized lab tests are needed to understand potential mutations that may boost infectiousness or enable immune evasion.

  • Bringing ‘deep learning’ to the clinic: scientists overcome key barrier to widespread adoption
    News

    Bringing ‘deep learning’ to the clinic: scientists overcome key barrier to widespread adoption

    By providing a new level of clarity into how deep learning systems reach their medical diagnoses, scientists hope this AI approach will fuel a new era of preventative medicine.

  • Through ‘All of Us’ program, Scripps Research launches wearable technology study to accelerate precision medicine
    News

    Through ‘All of Us’ program, Scripps Research launches wearable technology study to accelerate precision medicine

    Scientists will distribute 10,000 Fitbit devices in an effort to understand study participant engagement.

  • Important research antibodies get their close-up
    News

    Important research antibodies get their close-up

    Structural biologists have created the first-ever atomic-scale maps of antibodies bound to elusive molecules implicated in a range of diseases.

  • In Memoriam: Ralph A. Reisfeld, PhD (1926-2020)
    News

    In Memoriam: Ralph A. Reisfeld, PhD (1926-2020)

    Ralph Reisfeld, PhD, a longtime senior scientist at Scripps Research and pioneer in the fields of immunology and cancer, passed away at his La Jolla home on December 6, 2020. He was 94.

    Ralph Reisfeld
  • Scripps Research tracks prevalence of new COVID-19 variants with daily reports on Outbreak.info
    News

    Scripps Research tracks prevalence of new COVID-19 variants with daily reports on Outbreak.info

    To drive global research efforts, the Center for Viral Systems Biology at Scripps Research is tracking the prevalence of new variants of SARS-CoV-2 and making this information publicly available.

  • Chemist Hans Renata named 2021 Sloan Research Fellow
    News

    Chemist Hans Renata named 2021 Sloan Research Fellow

    A Scripps Research chemist who employs enzymes as tools to assemble useful natural compounds has been awarded a prestigious 2021 Sloan Research Fellowship for his work.

  • Scientists identify protein that may be silent cause of ‘iron overload’
    News

    Scientists identify protein that may be silent cause of ‘iron overload’

    A sensor protein plays an unexpected and important role in regulating iron levels in the body, according to a new study.

  • Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
    News

    Scientists urge for investment now in highly potent vaccines to prevent the next pandemic

    Warning that the next fast-spreading virus may not be as accommodating as the coronavirus driving COVID-19, they call for a new approach to pandemic preparedness.  

  • Scripps Research and Tempus collaborate to study how individual blood sugar levels vary
    News

    Scripps Research and Tempus collaborate to study how individual blood sugar levels vary

    The study will leverage genomics and digital technologies to better understand factors that contribute to obesity and type 2 diabetes. 

  • First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research
    News

    First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research

    A phase 1 trial testing a vaccine to prevent HIV has produced promising results, stimulating production of rare immune cells that begin the process of generating antibodies against the fast-mutating virus.

  • Experimental vaccine blunts the deadliest of synthetic opioids
    News

    Experimental vaccine blunts the deadliest of synthetic opioids

    In early tests, the vaccine was able to diminish fatal respiratory effects of fentanyl and carfentanil.

  • Ozanimod accepted for priority review by FDA for the treatment of ulcerative colitis
    News

    Ozanimod accepted for priority review by FDA for the treatment of ulcerative colitis

    The priority review is based on results from a placebo-controlled Phase 3 trial evaluating ozanimod as a therapy for moderately to severely active ulcerative colitis.

  • Kenan Trust contributes $1.8 million to science education at Scripps Research, Florida
    News

    Kenan Trust contributes $1.8 million to science education at Scripps Research, Florida

    Scripps Research, Florida has received a $1.8 million philanthropic gift from the William R. Kenan, Jr. Charitable Trust to support science education training.

  • Unraveling the mystery of Gao, a protein implicated in movement disorders
    News

    Unraveling the mystery of Gao, a protein implicated in movement disorders

    Through their discovery, scientists expanded what's known about how the brain controls muscles and may have opened the door to potential treatments for children with certain rare disorders.

  • Toward safer steroids: Scientists devise process for making precision anti-inflammatory medicines
    News

    Toward safer steroids: Scientists devise process for making precision anti-inflammatory medicines

    Scripps Research scientists engineer potentially safer glucocorticoids, a group of drugs used to treat COVID-19, auto-immune disease, and many other conditions.

  • Harvard Business Review Op-ed: Planning for the Next Pandemic
    News

    Harvard Business Review Op-ed: Planning for the Next Pandemic

    Scripps Research President Peter Schultz calls for investment in the development of anti-viral drugs to combat viruses most likely to cause the next global pandemic.

  • Eric Topol to receive Gold Foundation medal for humanism in healthcare
    News

    Eric Topol to receive Gold Foundation medal for humanism in healthcare

    Topol to be honored alongside Drs. Anthony Fauci and Wayne Riley, as well as hundreds of healthcare professionals for their dedication and compassion during the COVID-19 crisis.  

  • Gene regulator pumps iron to control sleep, inflammation and more, study finds
    News

    Gene regulator pumps iron to control sleep, inflammation and more, study finds

    Structural studies reveal the role of an iron-rich molecule, heme, in bringing together gene transcription factors involved in sleep, immunity and metabolism.

  • Ardem Patapoutian receives 2021 Frontiers of Knowledge Award from BBVA
    News

    Ardem Patapoutian receives 2021 Frontiers of Knowledge Award from BBVA

    Patapoutian is recognized for world-class research that provided the molecular basis for how temperature and pressure are perceived.

  • At least 1 in 3 people infected with COVID-19 never develop symptoms, according to new analysis
    News

    At least 1 in 3 people infected with COVID-19 never develop symptoms, according to new analysis

    Findings suggest COVID-19 testing should be expanded to those without symptoms who may be unknowingly spreading the virus to others.

  • Scripps Research CEO Peter Schultz wins National Academy of Sciences’ chemistry award for extraordinary scientific achievements
    News

    Scripps Research CEO Peter Schultz wins National Academy of Sciences’ chemistry award for extraordinary scientific achievements

    Schultz has made many innovative and pioneering contributions to the interface between chemistry and biology, including the rational expansion of the genetic code. 

Groundbreaking Science.
Life-changing Medicine.